+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
Methoxamine (CAS 390-28-3) Global Market Research Report 2024 - Product Thumbnail Image

Methoxamine (CAS 390-28-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
From
From
From
From
Loratadine (CAS 79794-75-5) Global Market Research Report 2024 - Product Thumbnail Image

Loratadine (CAS 79794-75-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Indacaterol (CAS 312753-06-3) Global Market Research Report 2024 - Product Thumbnail Image

Indacaterol (CAS 312753-06-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Histapyrrodine (CAS 493-80-1) Global Market Research Report 2024 - Product Thumbnail Image

Histapyrrodine (CAS 493-80-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Gefitinib (CAS 184475-35-2) Global Market Research Report 2024 - Product Thumbnail Image

Gefitinib (CAS 184475-35-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Fenoxazoline (CAS 4846-91-7) Global Market Research Report 2024 - Product Thumbnail Image

Fenoxazoline (CAS 4846-91-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Fenspiride (CAS 5053-06-5) Global Market Research Report 2024 - Product Thumbnail Image

Fenspiride (CAS 5053-06-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more